Voya Investment Management LLC Seagen Inc. Transaction History

Voya Investment Management LLC

$79.9 Billion
Q3 2024

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 14, 2023	BUY	$191.51 - $216.16 $5.54 Million - $6.25 Million	28,904 Added 18.65%	183,921 $39 Million
Q2 2023 Aug 14, 2023	SELL	$187.64 - $206.25 $96.9 Million - $106 Million	-516,279 Reduced 76.91%	155,017 $29.8 Million
Q1 2023 May 15, 2023	SELL	$127.59 - $203.08 $7.63 Million - $12.1 Million	-59,792 Reduced 8.18%	671,296 $136 Million
Q4 2022 Feb 28, 2023	BUY	$117.37 - $139.17 $36,502 - $43,281	311 Added 0.04%	731,088 $94 Million
Q4 2022 Feb 14, 2023	BUY	$117.37 - $139.17 $13.7 Million - $16.2 Million	116,490 Added 18.96%	730,777 $93.9 Million
Q3 2022 Mar 03, 2023	SELL	$135.27 - $180.11 $15.8 Million - $21 Million	-116,801 Reduced 15.98%	614,287 $84.1 Million
Q3 2022 Nov 14, 2022	BUY	$135.27 - $180.11 $9.04 Million - $12 Million	66,820 Added 12.21%	614,287 $84.1 Million
Q2 2022 Aug 15, 2022	SELL	$108.81 - $179.33 $1.47 Million - $2.43 Million	-13,532 Reduced 2.41%	547,467 $96.9 Million
Q1 2022 May 16, 2022	SELL	$119.61 - $157.85 $1.63 Million - $2.15 Million	-13,640 Reduced 2.37%	560,999 $80.8 Million
Q4 2021 Feb 14, 2022	SELL	$142.57 - $190.86 $13.3 Million - $17.8 Million	-93,375 Reduced 13.98%	574,639 $88.8 Million
Q3 2021 Nov 15, 2021	BUY	$142.45 - $169.82 $36.4 Million - $43.4 Million	255,497 Added 61.94%	668,014 $113 Million
Q2 2021 Aug 16, 2021	BUY	$135.08 - $161.1 $13.5 Million - $16.1 Million	100,056 Added 32.02%	412,517 $65.1 Million
Q1 2021 May 17, 2021	BUY	$137.51 - $190.8 $8.17 Million - $11.3 Million	59,398 Added 23.47%	312,461 $43.4 Million
Q4 2020 Feb 16, 2021	BUY	$164.63 - $211.93 $41.7 Million - $53.6 Million	253,063 New	253,063 $44.3 Million

Others Institutions Holding SGEN

# of Institutions

Shares Held

1.26M

Call Options Held

23K

Put Options Held

55.2K

View Full List

About Seagen Inc.

Ticker SGEN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 185,664,992
Description
Seagen Inc., a biotechnology company, develops and commercializes therapies for the treatment of cancer in the United States and internationally. The company offers ADCETRIS, an antibody-drug conjugate (ADC) for the treatment of patients with Hodgkin lymphoma or CD30-positive T-cell lymphomas; PADCEV, an ADC targeting Nectin-4 for the treatment ...

More about SGEN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Voya Investment Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Voya Investment Management LLC with notifications on news.

Account